-7.43
80,633.64
-0.01%
1,418.1
-0.17%
1,933.35
0.15%
-14.5
3,444.45
-0.42%
1,905.05
0.21%
1,424.35
-0.51%
3.1
777.25
0.4%
1,510
-0.09%
2,374.2
-0.3%
8,915
1.34%
-3.1
432.55
-0.71%
786.95
0.34%
3,326.55
-0.24%
1,797
-1.2%
1,573.6
-0.35%
2,084.05
0.49%
12,606.1
0.23%
3,095.75
0.86%
1,163.3
0.2%
11,640.4
-0.45%
1.2
342.95
0.35%
2,027.75
-0.23%
4,506
-0.02%
2.05
239
0.87%
3,360
1.87%
312.35
1.51%
1,336.5
1.22%
2,360
0.28%
4,015.7
0.24%
242.5
0.58%
674
4.04%
974
0.7%
382.35
1.06%
2,389.2
-1.19%
-20.15
2,334.85
-0.86%
310.1
-0.14%
231.5
-0.47%
7,913.85
-0.36%
536.9
0.18%
5,266.3
-1.07%
144.75
0.52%
2,701.9
-0.99%
12.55
5,234.8
0.24%
145.6
0.83%
421.1
1.87%
509.1
-0.96%
1,744.05
1.06%
-0.85
675.85
-0.13%
6,159
0.05%
415.7
1.21%
253.85
1.03%
-7.43
80633.64
-0.01%

CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Review
Ninad Ramdasi

Review

IOL CHEMICALS AND PHARMACEUTICALS 

Ticker : 524164 { FV: Rs. 10 { 52-Week H/L: Rs. 257.30/162.05 

We had previously recommended IOL Chemicals and Pharmaceuticals in volume 35, issue no. 39 (dated July 22, 2019), when the stock was trading at Rs 213.30. IOL Chemicals and Pharmaceuticals (IOLCP) is a leading organic chemicals manufacturer and supplier in India. The scrip was then recommended based on the company’s efforts to reduce its debt. On the standalone quarterly financial front, net sales increased by 6.89 per cent to Rs 511.25 crore in Q3FY20, from Rs 478.29 in Q3FY19. PBDT for Q3FY20 stood at Rs 159.70 crore, a growth of 29.30 per cent as compared to Rs 123.51 crore in Q3FY19. In Q3FY20, the net profit rose by 19.18 per cent to Rs 98.01 crore as compared to Rs 82.24 crore in Q3FY19. Since the company witnessed a positive growth momentum, we recommend to Book Profit at Rs 245.25 with a gain of 14.98 per cent as on February 18, 2020. 

Previous Article Fundamental Analysis
Next Article Technical Analysis
Print
152 Rate this article:
No rating
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR